Facilitating the Journey to Validated In-House NGS Workflows

In this webinar, Ludwig Macko, Head of Selector Development at Genedata, shares practical insights from real-world experiences on how to successfully validate in-house NGS workflows. He outlines a strategic, step-by-step approach tailored to the unique needs of biopharma organizations, ranging from configuring lab instruments to establishing robust, compliant methods. 

Discover how careful planning around infrastructure, resource allocation, governance, and stakeholder alignment can lay the foundation for scalable and future-ready NGS operations. Gain insight into how comprehensive documentation across all phases — from sequencing platforms and analytical methods to server environments — directly impacts validation success.

The Genedata QA team provides extensive expertise to support biopharma companies in optimizing their validation processes, accelerating timelines, and ensuring long-term value creation. Find out how automation with Genedata Selector enhances data processing and streamlines the path to regulatory readiness.

Who should watch? 

Professionals in biopharma and biotech focused on analytical development, biosafety, and quality control for cell and gene therapy products, as well as anyone involved in planning, executing, or overseeing NGS validation initiatives.